{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:33:28Z","timestamp":1787841208045,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dermatology as a branch is a panoramic canvas with a spectrum of manifestation, and psychodermatology is one emerging paradigm in its epicentre. Traditionally, it was thought that psychiatrists deal with \u201cinternal\u201d nonvisible disease, while dermatology centres around \u201cexternal\u201d visible dermatoses and cosmetic disfigurement, hence, with this belief, psychodermatology appeared as an oxymoron to many. Management of psychodermatological disorders requires a multidisciplinary approach, which includes a combination of psychopharmacology, psychotherapy and timely referral as and when needed. The commonly available psychotherapeutics at the disposal of dermatologists include antidepressants, mood stabilizers, antipsychotics, anxiolytics and sedative-hypnotics, the last three of which have been focused in this part of the review.<\/jats:p>","DOI":"10.4103\/ijd.ijd_916_23","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:00:35Z","timestamp":1734062435000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropic Drugs in Dermatology. Part 2: Antipsychotics, Sedative-Hypnotics and Anxiolytics in Dermatology"],"prefix":"10.4103","volume":"70","author":[{"given":"Ankita","family":"Choudhary","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, Venereology and Leprosy, Hindu Rao Hospital, North Delhi Municipal Corporation Medical College, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiti","family":"Bose","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, Department of Dermatology, City Hospital, Ernakulam, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Varsha","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, Department of Dermatology, Dr Surya\u2019s Skin Clinic, Secunderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4088\/PCC.v09n0306","article-title":"Psychodermatology: A guide to understanding common psychocutaneous disorders","volume":"9","author":"Jafferany","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"R2-20250228","doi-asserted-by":"crossref","first-page":"e13385","DOI":"10.1111\/dth.13385","article-title":"Psychotropic drugs in dermatology: A dermatologist's approach and choice of medications","volume":"33","author":"Jafferany","year":"2020","journal-title":"Dermatol Ther"},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clindermatol.2018.08.006","article-title":"Use of antipsychotic drugs in dermatology","volume":"36","author":"Gupta","year":"2018","journal-title":"Clin Dermatol"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaad.2012.04.007","article-title":"A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: How prepared are we?","volume":"68","author":"Gee","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250228","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-4362.1994.tb01019.x","article-title":"Nature and treatment of delusional parasitosis: A different experience in India","volume":"33","author":"Srinivasan","year":"1994","journal-title":"Int J Dermatol"},{"key":"R6-20250228","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0733-8635(05)70239-4","article-title":"Neurotropic and psychotropic drugs in dermatology","volume":"19","author":"Tennyson","year":"2001","journal-title":"Dermatol Clin"},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JCP.0b013e318185e774","article-title":"Second-generation antipsychotics in primary and secondary delusional parasitosis: Outcome and efficacy","volume":"28","author":"Freudenmann","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaad.2016.11.013","article-title":"Psychocutaneous disease: Clinical perspectives","volume":"76","author":"Kuhn","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250228","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1085-5629(03)00045-2","article-title":"Psychocutaneous drug therapy","volume":"22","author":"Lee","year":"2003","journal-title":"Semin Cutan Med Surg"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:ACLI.0000008687.21295.8a","article-title":"Atypical antipsychotics in the treatment of delusional parasitosis","volume":"15","author":"Wenning","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clindermatol.2018.08.006","article-title":"Use of antipsychotic drugs in dermatology","volume":"36","author":"Gupta","year":"2018","journal-title":"Clin Dermatol"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0190-9622(86)70081-9","article-title":"Psychotropic drugs in dermatology. A review and guidelines for use","volume":"14","author":"Gupta","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.abd.2019.12.002","article-title":"Use of psychiatric drugs in Dermatology","volume":"95","author":"Weber","year":"2020","journal-title":"An Bras Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_916_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:43:33Z","timestamp":1787838213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_916_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_916_23","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"2023-09-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}